Section: NATURAL SCIENCES Open Access Logo

Molecular cloning and isolation of a recombinant alpha-Momorcharin in E. coli against Pyricularia oryzae

Thao Thu Thi Nguyen 1
Dung Thanh Dang 1, *
  1. Ho Chi Minh City Open University, Vietnam
Correspondence to: Dung Thanh Dang, Ho Chi Minh City Open University, Vietnam. Email: dangthanhdung0018036@yahoo.com.
Volume & Issue: Vol. 26 No. 1 (2023) | Page No.: 2665-2671 | DOI: 10.32508/stdj.v26i1.4023
Published: 2023-04-15

Online metrics


Statistics from the website

  • Abstract Views: 1583
  • Galley Views: 578

Statistics from Dimensions

Copyright The Author(s) 2023. This article is published with open access by Vietnam National University, Ho Chi Minh city, Vietnam. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Introduction: Alpha-Momorcharin (α-MMC) is a member of the ribosome-inactivating protein (RIP) family that has been widely used as an antitumor, antiviral and antifungal agent.

Methods: In this study, the codons of DNA encoding α-MMC were optimized for expression in E. coli and cloned into the pET-28a(+) vector. The protein was then expressed in E. coli strain BL21 (DE3) and purified by nickel affinity chromatography.

Results: Under IPTG induction, α-MMC was expressed at approximately 50% of the total protein, showing high-level recombinant protein expression in E. coli. A high amount of purified α-MMC (70 mg) was isolated from 1 L LB culture medium of E. coli BL21 (DE3) with approximately 95% purity. Interestingly, α-MMC inhibited the mycelial growth of Pyricularia oryzae in a concentration-dependent manner.

Conclusion: Using a microbial system for α-MMC expression provides a promising method for the design of a new agent against pathogens.

INTRODUCTION

Ribosome-inactivating proteins (RIPs) are found in many plant species within different tissues. RIPs can act as protein synthesis inhibitors because of their toxicity with the ability to biologically inhibit the synthesis of proteins based on N-glycosidase activity 1. The potential applications of RIPs have been widely studied in both medicine and agriculture (Figure 1)2, 3. In medicine, RIPs are fused with antibodies or other carriers to generate immunotoxins or toxic agents to cancer cells2, 4, 5, 6. In agriculture, RIPs are expressed in plants under stressful conditions to resist infection by pathogens such as viruses, fungi and insects7, 8, 9, 10, 11.

Alpha-Momorcharin (α-MMC) belongs to a member of the ribosome-inactivating protein (RIP) family, which is abundantly found in the seeds of 12, 13, 14.The α-MMC protein has various important agricultural activities, such as antifungal and antiviral activities 7, 15, 16. Insight into the mechanism of α-MMC against fungal and viral pathogens has been studied. α-MMC can directly inhibit pathogens by entering the cell wall through the endoplasmic reticulum, leading to inhibition of protein synthesis, thereby inhibiting fungal growth and killing fungal cells16. However, there is increasing evidence that the main cause of toxicity in germ cells is their ability to induce reverse inhibition of apoptosis. α-MMC inhibits the synthesis of protein by hydrolytically removing a specific residue of adenine from a single-stranded loop of rRNA 1. The hydrolysis of the N-glycosidic bond takes place on the highly conserved Sarcin/Ricin Loop region of the rRNA, which interrupts the interaction of elongation factor II (EF-2), causing the ribosome to fail to bind and ultimately inhibit protein synthesis at the translation step, causing cell death 17.

Figure 1

Ribosome-inactivating proteins (RIPs) have antitumor, anti-inflammatory, antifungal and antiviral activities.

Many studies have demonstrated that the α-MMC protein plays an important role in many fields. The most promising application of α-MMC in medicine is in the prevention of cancer. α-MMC has also been shown to inhibit the growth of breast cancer cells through inhibition of tumor growth and induction of apoptosis6, 18, 19, 20, 21, 22. In addition, α-MMC is a potential therapeutic agent for HIV/AIDS via its ability to inhibit HIV replication in acutely and chronically infected cells23, 24. In agriculture, the α-MMC protein showed a wide range of antiviralactivity (resistant to )16 and antifungal activity (resistant to ) 11. In fact, extraction of α-MMC protein from the seeds of bitter melon by traditional techniques has limited the mass of protein for studying the structure and biological functions of traditional approaches25. In this study, we aimed to clone, express, and purify α-MMC protein with high purity in an system. The isolated protein was used to resist . This finding shows great promise for the expansion of potential α-MMC protein applications against pathogens.

MATERIALS AND METHODS

Construction of plasmid

A target α-MMC protein was generated in plasmid pET28a(+). The DNA sequence encoding α-MMC was obtained from GenBank (CAA40869.1). DNA of which was optimized by the codon optimization tool from Integrated DNA Technologies (IDT) for expression in the system 26, was then synthesized by the Macrogen company (Korea).DNA encoding α-MMC was amplified by PCR using the gene (optimal codons, IDT, USA) as the template and the primer pair ONF/ONR (ONF: 5'-cag cca tat gga tgt tag ctt tcg ttt gtc ggg tgc tga t -3'; ONR: 5'- ggt gct cga gtc agt agc tcg aaa agc cat gtg -3'). The pcr product was inserted into treated pET28a(+) (Merck Millipore, Germany) at the I and I sites by T4 DNA ligase, resulting in the generation of the plasmid pET-MMC.

Amino acid sequence of α-MMC protein:

MGSSHHHHHHHHSSGLVPRGSHMDVSFRL

SGADPRSYGMFIKDLRNALPFREKVYNIPLLL

PSVSGAGRYLLMHLFNYDGKTITVAVDVTNV

YIMGYLADTTSYFFNEPAAELASQYVFRDARR

KITLPYSGNYERLQIAAGKPREKIPIGLPALDSA

ISTLLHYDSTAAAGALLVLIQTTAEAARFKYIEQ

QIQERAYRDEVPSLATISLENSWSGLSKQIQLA

QGNNGIFRTPIVLVDNKGNRVQITNVTSKVVT

SNIQLLLNTRNIAEGDNGDVSTTHGFSSY

Expression and purification of proteins

The plasmid pET-MMC encoding the α-MMC protein was chemically transformed into strain BL21 (DE3). The bacteria were cultured in Luria-Bertani medium (LB) containing 40 mg/L kanamycin, and the cells were grown at 37 °C with shaking at 200 rpm to reach an OD600 of 0.8-1. IPTG (Sigma Aldrich, St. Louis, USA) was subsequently added to a final concentration of 0.75 mM. The cells were continuously incubated for 10 hours at 15 °C with shaking at 200 rpm before being harvested by centrifugation. The pellet was then resuspended in lysis buffer consisting of 20 μg/ml DNase I and 1 mM PMS. The cell wall was broken by sonication, and the insoluble cell debris was then removed by centrifugation at 20000 rpm for 1 hour at 4 °C. The soluble fraction was added to a His-tag column (Thermo Fisher Scientific, Waltham, MA, USA). Subsequently, the column was washed with 30 volumes of column with 20 mM Tris-HCl, 100 mM NaCl and 10 mM imidazole buffer, pH 7. The proteins were finally eluted with buffer containing 20 mM Tris-HCl, 100 mM NaCl and various imidazole concentrations. The imidazole chemical in the protein solution was removed by centrifugation using an Amicon Ultra15 centrifugal filter (EMD Milipore). The pure α-MMC protein was collected and analyzed by SDS‒PAGE. Total protein expression was analyzed by AlphaEase software. The pure protein was measured by a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA).

Testing the antifungal activity of α-MMC against pathogens

Initial experiments investigated the antifungal activity against . The α-MMC protein with different concentration ranges and control (water) samples were evenly added to the surface of the PDA-agar plate. Subsequently, the fungal suspension and control water samples were added into the center of the PDA-agar plate and incubated for 24 hours at 28 °C 27.

RESULTS

Construction of plasmid pET-MMC

The DNA sequence of was first optimized for expression in an system by the codon optimization tool from Integrated DNA Technologies (IDT). The gene was provided with the best sequence option by screening and filtering sequences to lower complexity and minimize secondary structures. The gene fragment was amplified by PCR with a pair of specific primers ONF and ONR with additional restriction enzyme cutting sites I (forward primer) and I (reverse primer). PCR products were analyzed by gel electrophoresis with 2% agarose, which showed a single bright band near the 800 bp band of the DNA ladder (Figure 2A), corresponding to the theoretical size of the α-MMC gene fragment of 812 bp.

The pET28 plasmid and the target gene after treatment with 2 restriction enzymes, I and I, were cloned by T4 DNA ligase. The ligated product was transformed into strain DH5α and spread on LB-agar medium containing the antibiotic kanamycin. The colonies grown on the medium were selected to clarify the presence of recombinant vector in strain DH5α by colony PCR. The electrophoresis results showed that 2 colonies (in 7 selected colonies) revealed a band at approximately 1000 bp of the DNA ladder, corresponding to the theoretical size design (1055 bp) (Figure 2B). The recombinant DNA was then sequenced by Macrogen. Inc. (Korea). The sequencing result revealed 100% similarity with the theoretical sequence (data not shown) that clarifies the recombinant vector pET-MMC bearing the gene.

Figure 2

DNA electrophoresis.A) PCR product of the α-MMC gene (812 bps). (B) PCR products (1055 bps) of 7 random colonies from the culture plate, M (DNA Marker).

Protein expression and purification

To investigate the expression of the α-MMC protein in a bacterial system, the recombinant plasmid pET-MMC was chemically transformed into the strain BL21(DE3). The IPTG for induction was added after the cells were grown to reach OD0.8-1. The level of protein expression was analyzed by SDS‒PAGE. The results showed that there was a bright band of protein near the 30 kDa band of the ladder, corresponding to the theoretical molecular weight of the α-MMC protein (31.388 Da) under the addition of IPTG. In contrast, the α-MMC protein was not expressed without the addition of IPTG. Using the Software (Alpha Innotech) for calculation of protein expression 28, the α-MMC protein was expressed with a high protein level in of approximately 50% of total protein under induction of IPTG (Figure 3A).

The α-MMC protein was designed with 6xHis for purification. α-MMC fused with a His-tag at the N-terminus was purified by chromatography using the His-tag column. SDS‒PAGE showed that pure α-MMC was collected after elution with different concentrations of imidazole (Figure 3B). The molecular weight of α-MMC is 31.388 Da, which shifted near the 30 kDa band of the ladder. Using the NanoDrop spectrophotometer to measure the protein concentration (total protein fragments with imidazole concentrations of 100 to 200 mM), approximately 70 mg of pure α-MMC was obtained in 1L LB culture medium, which implies that α-MMC can be highly expressed in bacterial systems.

Figure 3

SDS‒PAGE of α-MMC protein. A) Protein expression in E. coli with (+) and without (-) IPTG inducer. B) Homogeneous α-MMC was eluted with different concentrations of imidazole, M (protein marker).

Effect of α-MMC protein on mycelial growth of and

Theα-MMC protein has previously been shown to confer resistance to fungi by blocking the spread of pathogens. In this study, we tested the antifungal activity of the α-MMC protein against (causing blast disease). Compared with the control, the difference between treatments with variant α-MMC protein concentrations was evident in the assays. Treatments with 5 µM, 20 µM, 100 µM and 200 µM α-MMC against (Figure 4) showed that the mycelial growth of fungi was inhibited in a concentration-dependent fashion after 24 hours of incubation. Specifically, for treated with water as the control, the fungal colonies were brown in color and spread over the plate. At low concentrations of α-MMC (5 µM and 20 µM), the inhibition of fungal growth was still weak, with a diameter of fungal colonies of 3.4 cm. Increasing concentrations of α-MMC at 100 µM and 200 µM clearly showed antimicrobial activity against the blast fungus with a colony diameter of 1.75 cm and nonfungal growth, respectively (Figure 4).

Figure 4

Testing of antifungal activity of protein α-MMC. Growth inhibition of Pyricularia oryzae on PDA medium at different concentrations of α-MMC: control (water), 0 µM, 5 µM, 20 µM, 100 µM and 200 µM. All experiments were incubated for 24 h at 28 °C.

DISCUSSION

RIPs (ribosome-inactivating proteins) have attracted the attention of biologists in the field of biomedical research because of their diverse activities, including anticancer, antiviral and anti-inflammatory effects. Many studies have demonstrated that RIPs are potent protein toxins with diverse biopharmacological properties, notably rRNA N-glycosidase activity1. α-MMC is a member of the RIP family that has been extracted from the seeds of and plays a role in antitumor, antiviral, and antifungal activities. However, the biological functions of α-MMC are still not fully understood, partly because of the difficulty in purifying this protein from seeds with traditional approaches25. Mass production of α-MMC is needed for further studies of functional analysis and applications. Using the system for the expression of α-MMC has been considered an efficient approach for producing high amounts of protein. Herein, optimization of codons for expression in the system allows lower complexity and minimizes secondary structures. The expression of α-MMC in strain BL21 (DE3) was approximately 50% of the total proteins under the induction of IPTG, indicating high-level recombinant protein expression in the bacterial system. Using the His-tag column, approximately 70 mg of α-MMC with 95% purity was isolated from 1 L LB culture medium. This shows that α-MMC is expressed in the soluble phase and can easily be purified for functional analysis. Preliminary data showed that α-MMC was able to inhibit the mycelial growth of in a concentration-dependent fashion. This is in line with a previous study of α-MMC activity against other fungi, such as and 11. The fungal-inhibiting activity of α-MMC may be involved in RNA N-glycosidase and nuclease activities 11.

CONCLUSIONS

In this study, the pET-MMC vector carrying an target gene was genetically generated. This recombinant vector was able to be expressed in an system with a high amount of α-MMC protein in the presence of the inducer IPTG. The α-MMC protein was homogeneously isolated by chromatography using a His-tag column. Preliminary results showed that α-MMC had activity against . This is the basis for further studies, including detailed evaluation of the growth inhibition of mycelium for investigation of the anticancer, anti-inflammatory, antifungal and antiviral activities.

COMPETING INTERESTS

There is no conflict of interest.

AUTHORS' CONTRIBUTIONS

D.T.D designed and T.T.T.N performed all experiments. T.T. and D.T. wrote the paper.

ACKNOWLEDGMENTS

We would like to thank Dr. Le Thi Truc Linh and Ms. Duong Nhat Linh (Ho Chi Minh City Open University, Vietnam) for kindly providing fungi.

ABBREVIATIONS

α-MMC: Alpha-Momorcharin

EF-2: Elongation factor II

IDT: Integrated DNA Technologies

IPTG: Isopropyl β- d-1-thiogalactopyranoside

LB: Luria-Bertani medium

PCR: Polymerase chain reaction

PDA: Potato Dextrose Agar

RIPs: Ribosome-inactivating proteins

SDS‒PAGE: Sodium dodecyl-sulfate polyacrylamide gel electrophoresis

References

  1. . Ren J, Wang Y, Dong Y, Stuart DI. The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. Structure. 1994;2(1):7-16. :
  2. . Lu JQ, Zhu ZN, Zheng YT, Shaw PC. Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties. Toxins (Basel). 2020;12(3). :
  3. . Puri M, Kaur I, Perugini MA, Gupta RC. Ribosome-inactivating proteins: current status and biomedical applications. Drug Discov Today. 2012;17(13-14):774-83. :
  4. . Deng N, Sun Y, Liu M, He Q, Wang L, Zhang Y, et al. Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes. Immunopharmacol Immunotoxicol. 2019;41(2):258-66. :
  5. . Zeng M, Zheng M, Lu D, Wang J, Jiang W, Sha O. Antitumor activities and apoptotic mechanism of ribosome-inactivating proteins. Chin J Cancer. 2015;34(8):325-34. :
  6. . Cao D, Sun Y, Wang L, He Q, Zheng J, Deng F, et al. Alpha-momorcharin (alpha-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo. Fitoterapia. 2015;100:139-49. :
  7. . Zhu F, Zhu PX, Xu F, Che YP, Ma YM, Ji ZL. Alpha-momorcharin enhances Nicotiana benthamiana resistance to tobacco mosaic virus infection through modulation of reactive oxygen species. Mol Plant Pathol. 2020;21(9):1212-26. :
  8. . Zhu F, Zhou YK, Ji ZL, Chen XR. The Plant Ribosome-Inactivating Proteins Play Important Roles in Defense against Pathogens and Insect Pest Attacks. Front Plant Sci. 2018;9:146. :
  9. . Yang T, Zhu LS, Meng Y, Lv R, Zhou Z, Zhu L, et al. Alpha-momorcharin enhances Tobacco mosaic virus resistance in tobacco(NN) by manipulating jasmonic acid-salicylic acid crosstalk. J Plant Physiol. 2018;223:116-26. :
  10. . Yang T, Meng Y, Chen LJ, Lin HH, Xi DH. The Roles of Alpha-Momorcharin and Jasmonic Acid in Modulating the Response of Momordica charantia to Cucumber Mosaic Virus. Front Microbiol. 2016;7:1796. :
  11. . Wang S, Zhang Y, Liu H, He Y, Yan J, Wu Z, et al. Molecular cloning and functional analysis of a recombinant ribosome-inactivating protein (alpha-momorcharin) from Momordica charantia. Appl Microbiol Biotechnol. 2012;96(4):939-50. :
  12. . Yao X, Li J, Deng N, Wang S, Meng Y, Shen F. Immunoaffinity purification of alpha-momorcharin from bitter melon seeds (Momordica charantia). J Sep Sci. 2011;34(21):3092-8. :
  13. . Zhu G, Huang Q, Qian M, Tang Y. Crystal structure of alpha-momorcharin in 80% acetonitrile--water mixture. Biochim Biophys Acta. 2001;1548(1):152-8. :
  14. . Feng Z, Li WW, Yeung HW, Chen SZ, Wang YP, Lin XY, et al. Crystals of alpha-momorcharin. A new ribosome-inactivating protein. J Mol Biol. 1990;214(3):625-6. :
  15. . Qian Q, Huang L, Yi R, Wang S, Ding Y. Enhanced resistance to blast fungus in rice (Oryza sativa L.) by expressing the ribosome-inactivating protein alpha-momorcharin. Plant Sci. 2014;217-218:1-7. :
  16. . Zhu F, Zhang P, Meng YF, Xu F, Zhang DW, Cheng J, et al. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro. Planta. 2013;237(1):77-88. :
  17. . Wang S, Zheng Y, Yan J, Zhu Z, Wu Z, Ding Y. Alpha-momorcharin: a ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties. Protein Pept Lett. 2013;20(11):1257-63. :
  18. . Manoharan G, Jaiswal SR, Singh J. Effect of alpha, beta momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines. Mol Cell Biochem. 2014;388(1-2):233-40. :
  19. . Bian X, Shen F, Chen Y, Wang B, Deng M, Meng Y. PEGylation of alpha-momorcharin: synthesis and characterization of novel antitumor conjugates with therapeutic potential. Biotechnol Lett. 2010;32(7):883-90. :
  20. . Li M, Chen Y, Liu Z, Shen F, Bian X, Meng Y. Antitumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol. Acta Biochim Biophys Sin (Shanghai). 2009;41(9):792-9. :
  21. . Ng TB, Liu WK, Sze SF, Yeung HW. Action of alpha-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines. Gen Pharmacol. 1994;25(1):75-7. :
  22. . Tsao SW, Ng TB, Yeung HW. Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines. Toxicon. 1990;28(10):1183-92. :
  23. . Zheng YT, Ben KL, Jin SW. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes. Zhongguo Yao Li Xue Bao. 1999;20(3):239-43. :
  24. . Leung KC, Meng ZQ, Ho WK. Antigenic determination fragments of alpha-momorcharin. Biochim Biophys Acta. 1997;1336(3):419-24. :
  25. . Dela-Pena C, Badri DV, Vivanco JM. Novel role for pectin methylesterase in Arabidopsis: a new function showing ribosome-inactivating protein (RIP) activity. Biochim Biophys Acta. 2008;1780(5):773-83. :
  26. . Kudla G, Murray AW, Tollervey D, Plotkin JB. Coding-sequence determinants of gene expression in Escherichia coli. Science. 2009 10;324(5924):255-8. :
  27. . Wang S, Zheng Y, Xiang F, Li S, Yang G. Antifungal activity of Momordica charantia seed extracts toward the pathogenic fungus Fusarium solani L.J FoodDrug Anal.2016;24(4):881-7. :
  28. . Bakhtiari N, Amini Bayat Z, Sagharidouz S, Vaez M. Overexpression of Recombinant Human Teriparatide, rhPTH (1-34) in Escherichia coli : An Innovative Gene Fusion Approach. Avicenna J Med Biotechnol. 2017 ;9(1):19-22. :

Comments